Which has grown faster, PTCT or TVTX?

Over the past five years, TVTX grew revenue faster — PTCT at a 16.41% CAGR versus TVTX at 23.71%.

How have PTCT and TVTX total returns compared?

Over the past 10 years, PTCT delivered 16.60% and TVTX delivered 9.57% annualized total return. Past performance doesn't predict future results.

PTC Therapeutics, Inc. (PTCT) vs Travere Therapeutics, Inc. (TVTX)

A side-by-side comparison of PTC Therapeutics, Inc. and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

PTCT

PTC Therapeutics, Inc.

$5.32B

$63.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TVTX

Travere Therapeutics, Inc.

$5.21B

$55.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — PTCT vs TVTX

growth of $100 · dividends reinvested · last 10y

PTCT +376.4% (+16.9%/yr)TVTX +150.2% (+9.6%/yr)PTCT compounded faster over this window

PTCT TVTX

PTCT vs TVTX: by the numbers

•PTCT is the larger company ($5.32B vs $5.21B market cap).
•Both run net losses; PTCT's is the smaller (-3.80% vs -7.35% net margin).
•TVTX grew revenue faster over the past five years (23.71% vs 16.41% CAGR).

Metrics side by side

Valuation

Metric	PTCT	TVTX
Forward P/E	50.13	N/A
P/S ratio	5.27	8.80
P/B ratio	N/A	212.29
EV / EBITDA	28.93	248.98
FCF yield	N/A	0.99%

Profitability

Metric	PTCT	TVTX
Gross margin	95.85%	94.41%
Operating margin	49.49%	-6.84%
Net margin	-3.80%	-7.35%
ROE	N/A	-177.24%
ROIC	4.59%	-6.19%

Growth (annualized)

Metric	PTCT	TVTX
Revenue CAGR (5Y)	16.41%	23.71%
Total return CAGR (5Y)	11.75%	17.83%

Frequently asked

Which has grown faster, PTCT or TVTX?: Over the past five years, TVTX grew revenue faster — PTCT at a 16.41% CAGR versus TVTX at 23.71%.
How have PTCT and TVTX total returns compared?: Over the past 10 years, PTCT delivered 16.60% and TVTX delivered 9.57% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PTCT analysis Full TVTX analysis Interactive comparison tool

Dig into the metrics

PTC Therapeutics ROE Travere Therapeutics ROE PTC Therapeutics operating margin Travere Therapeutics operating margin PTC Therapeutics revenue growth Travere Therapeutics revenue growth PTC Therapeutics free cash flow Travere Therapeutics free cash flow

PTC Therapeutics & Travere Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.